1 completed. 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 3 | 1 | Completed 1 |
Follow NNC0195-0092: new trials by email Literature Review of NNC0195-0092 trials Research Report on NNC0195-0092
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Trial to Compare the Efficacy and Safety of NNC0195-0092 (Somapacitan) With Placebo and Norditropin® FlexPro® (Somatropin) in Adults With Growth Hormone Deficiency. somapacitan, somatropin, placebo - Growth Hormone Disorder, Adult Growth Hormone Deficiency | Phase 3 | Completed | Novo Nordisk A/S | 301 | 2014-10-31 | 2020-11-23 |
Novo Nordisk A/S (1)
Australia (1) · Brazil (1) · Germany (1) · India (1) · Israel (1) · Japan (1) · Latvia (1) · Lithuania (1) · Malaysia (1) · Norway (1) · Poland (1) · Romania (1) · Russia (1) · South Africa (1) · Sweden (1)